Abstract
To assess the genotypic determinants of the virological response (VR) to didanosine (ddI) in nucleoside reverse transcriptase inhibitors (NRTI)-experienced patients. Human immunodeficiency virus type 1 (HIV-1) genotype was determined at baseline in 74 ddI-naive-patients with baseline viral load >500 copies/ml and receiving ddI as part of a new regimen. VR was defined as a plasma HIV-1 RNA <50 copies/ml after three months on ddI. NRTI resistance mutations associated with higher or lower frequencies of VR with a p-value<0.25 were retained in different sets of mutations, where the mutations associated with a worse VR were added, whereas the mutations associated with a better VR were subtracted. The most significant mutation scores were then studied in a multivariate analysis. Changes at three codons (M41L, L210W, T215Y/F/D/C/E) were associated with a worse VR and three mutations (K70R, M184V, K219Q) with a better VR. The strongest association with the VR was obtained with the score M41L+L210W+T215Y/F/D/C/E-K70R-K219Q. The score was independently associated with the VR in the multivariate analysis. Taking into account the mutations associated with a better VR may improve genotypic resistance algorithms. Our results are of interest ...Continue Reading
References
Sep 27, 1991·Science·M H St ClairB A Larder
Dec 1, 1989·Science·B A Larder, S D Kemp
Feb 1, 1994·Antimicrobial Agents and Chemotherapy·D ZhangR T D'Aquila
Mar 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·T ShirasakaR Yarchoan
Jun 1, 1993·Antimicrobial Agents and Chemotherapy·Q GaoM A Wainberg
Nov 20, 1998·The Journal of Clinical Investigation·M A WintersT C Merigan
Oct 6, 1999·AIDS·I PellegrinM Segondy
Jul 18, 2000·Antimicrobial Agents and Chemotherapy·K Van VaerenberghA M Vandamme
May 17, 2001·Antimicrobial Agents and Chemotherapy·B MasquelierUNKNOWN ANRS AC11 Resistance study group. French Agence Nationale de Recherches sur le SIDA
Sep 7, 2001·Journal of Virological Methods·P MerelH Fleury
Mar 9, 2002·Journal of Virology·Paul L BoyerStephen H Hughes
Jun 28, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Martin S HirschDouglas D Richman
Jul 30, 2003·Journal of Virology·Karidia DialloMark A Wainberg
Aug 5, 2003·The Journal of Infectious Diseases·Mark A WintersUNKNOWN AIDS Clinical Trials Group 364 Study Team
Sep 27, 2003·The Journal of Infectious Diseases·Jeannette M WhitcombChristos J Petropoulos
Feb 21, 2004·The Journal of Infectious Diseases·Michael D MillerMichael Wulfsohn
Apr 28, 2005·Antimicrobial Agents and Chemotherapy·Anne-Geneviève MarcelinUNKNOWN AI454-176 Jaguar Study Team
Citations
Nov 17, 2007·The Journal of Infectious Diseases·Andrea De LucaAndrea Antinori
Oct 30, 2009·AIDS·Lambert AssoumouUNKNOWN Standardization, Clinical Relevance of HIV Drug Resistance Testing Project from the Forum for Collaborative HIV Research
Jun 30, 2007·Drugs·Santiago MorenoFernando Dronda
Aug 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Laurence GérardEric Oksenhendler